MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28
Medinotec Inc.
Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$5.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $58.78M
- P/E (TTM)
- –
- Dividend yield
- –
Medinotec Inc. revenue by segment
By business segment
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Outside The United States [Member] | $9.12M | $8.44M | $4.47M | $978.11K | 93.7% | +8.1% |
| Outside U S A Distribution Agreement Sales [Member] | $8.14M | $7.57M | $3.49M | – | 83.7% | +7.5% |
| Outside U S A Internally Designed Manufactured Sales [Member] | $975.97K | $863.34K | $976.29K | $978.11K | 10.0% | +13.0% |
| Inside The United States [Member] | $611.86K | $678.11K | $553.97K | $21.47K | 6.3% | -9.8% |
| Inside U S A Internally Designed Manufactured Sales [Member] | $611.86K | $678.11K | $553.97K | $21.47K | 6.3% | -9.8% |
| Operating income | FY2026 | FY2025 | FY2024 | FY2023 | YoY |
|---|---|---|---|---|---|
| Outside The United States [Member] | $1.66M | $3.44M | $602.16K | $10.82K | -51.9% |
| Inside The United States [Member] | -$560.61K | -$251.20K | -$1.58K | -$249.41K | +123.2% |
By product or service
By region
From the segment and revenue-disaggregation notes of Medinotec's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.